ATLANTA, GA - July 24, 2025 (NEWMEDIAWIRE) - GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, ...
KEYNOTE-689 established perioperative pembrolizumab (two preoperative cycles) as event-free survival–improving therapy for resectable, locally advanced disease, supporting FDA approval and adoption ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results